Medicine and Dentistry
Ovarian Cancer
100%
Uterine Cancer
39%
Enhanced Recovery After Surgery
37%
Diseases
33%
Malignant Neoplasm
29%
Health Care Cost
29%
Gynecological Surgery
28%
Gynecological Oncology
28%
Patient-Reported Outcome
28%
Female Genital Tract Cancer
26%
Cervical Cancer
22%
Overall Survival
22%
Neoadjuvant Chemotherapy
18%
Radiation Therapy
16%
Hazard Ratio
15%
Neoplasm
15%
Cancer
14%
Chemoradiotherapy
13%
Odds Ratio
12%
Cytoreductive Surgery
12%
Quality of Life
11%
BRCA1
10%
Cancer Diagnosis
10%
Proportional Hazards Model
10%
Progression Free Survival
9%
Surgery
9%
Medicare
9%
Cancer Risk
9%
Retroperitoneal Lymph Node Dissection
9%
Postoperative Complication
8%
Comorbidity
8%
Cancer Surgery
8%
BRCA2
7%
Body Mass Index
7%
PARP Inhibitor
7%
Cost-Effectiveness Analysis
7%
Recurrent Disease
7%
Krukenberg Tumor
7%
Endometrium Carcinoma
7%
Clinical Oncology
7%
Symptomatic Treatment
6%
Morphine
6%
Bowel Obstruction
6%
Carboplatin
6%
Urinary System
6%
Logistic Regression Analysis
5%
Venous Thromboembolism
5%
Perioperative Period
5%
Hysterectomy
5%
Reoperation
5%
Keyphrases
Ovarian Cancer
42%
Endometrial Cancer
16%
Cervical Cancer
16%
Gynecological Cancer
14%
Chemotherapy
14%
Enhanced Recovery after Surgery (ERAS®)
14%
Neoadjuvant Chemotherapy
14%
Overall Survival
14%
Advanced Ovarian Cancer
13%
Gynecologic Surgery
13%
United States
13%
Patient-reported Outcomes
11%
Confidence Interval
11%
Medicaid Expansion
10%
Hazard Ratio
9%
Ovarian Cancer Patients
9%
Odds Ratio
8%
Newly Diagnosed
7%
Clinical Oncology
7%
Endometrial Carcinoma
7%
Clinical Practice Guidelines
7%
American Society of Clinical Oncology
7%
Difference-in-differences
6%
Estrogen
6%
Tumor
6%
Chemoradiation
5%
Genetic Variants
5%
Cancer-specific Survival
5%
Radiation Therapy
5%
Primary Cytoreductive Surgery
5%
Gynecologic Oncology
5%
Lymphadenectomy
5%
Difference Analysis
5%
Progression-free Survival
5%